Document Details

Form
Filing Date
August 31, 2022
Document Date
August 31, 2022
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
Sofgen Pharma
Issuer
SOFGEN PHARMA S.A.

Investor Contact Information

Company

Sofgen Pharma
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Sofgen Pharma Company Contact
ir@SofgenPharma.com

Search Investor Relations